Irina Antonijevic - Dec 29, 2023 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Dec 29, 2023
Transactions value $
-$459,663
Form type
4
Date filed
12/29/2023, 06:25 PM
Previous filing
May 4, 2023
Next filing
May 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $0 +11K +433.93% $0.00 13.5K Dec 29, 2023 Direct
transaction BHVN Common Shares Sale -$460K -11K -81.27% $41.79 2.54K Dec 29, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to Buy) Options Exercise $0 -11K -8.8% $0.00 114K Dec 29, 2023 Common Shares 11K $7.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.74 - $41.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2 The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date.